Financial statements Dopharma Polska

Balance sheet of Dopharma Polska

Company age:
Age:
5 y. 2 m. 25 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of DOPHARMA POLSKA

Year
2020
2022
2023
Total assets 12 633 285,92 19 612 982,69 21 211 432,13
A. Fixed assets 3 768,90 1 936 621,22 2 868 169,29
B. Current assets 12 629 517,02 17 676 361,47 18 343 262,84
C. Share capital contributions (basic funds) - - -
D. Own shares (stocks) - - -
Total liabilities 12 633 285,92 19 612 982,69 21 211 432,13
A. Equity -2 257 940,00 2 102 153,27 4 046 370,92
B. Liabilities and provisions for liabilities 14 891 225,92 17 510 829,42 17 165 061,21
I. Long-term liabilities 646 790,63 446 115,69 528 472,40
II. Short-term liabilities 13 319 955,89 14 778 288,09 14 072 639,59
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.